Table 6.
Live birth outcomes of the 865 ICSI cycles.
| hMG | HP-hMG | r-hFSH | p value | |
| Cycles with live births, n | 73 | 107 | 71 | |
| Single, n (%) | 50 (68.5) | 68 (63.5) | 46 (64.8) | 0.57 |
| Twins, n (%) | 18 (24.7) | 34 (31.8) | 22 (31.0) | 0.59 |
| Triplets, n (%) | 5 (6.8) | 5 (4.7) | 3 (4.2) | 0.89 |
| Mean gestational age, weeks (± SD) | ||||
| Single | 36.5 (± 3.6)a | 38.1 (± 2.1)b | 38.3 (± 2.3)c | 0.01 (a vs b, c) |
| Twins | 35.0 (± 0.8)a | 35.1 (± 3.0)b | 37.3 (± 2.7)c | 0.03 (a, b vs c) |
| Triplets | 29.3 (± 3.5)a | 31.1 (± 3.4)b | 34.0 (± 0.0)c | 0.03 (a vs c) |
| Mean weight, g (± SD) | ||||
| Single | 2882 (± 703) | 3064 (± 470) | 3024 (± 334) | 0.09 |
| Twins | 2352 (± 436)a | 2067 (± 614)b | 2230 (± 715)c | 0.01 (a vs b) |
| Triplets | 1250 (± 329)a | 1470 (± 448)b | 1747 (± 196)c | 0.03 (a vs c) |
Cycles with live births in relation to the parity and gestational outcomes of the babies from 865 ICSI cycles with menotropin (hMG), highly-purified menotropin (HP-hMG) or follitropin alfa (r-hFSH) used for COH. Overall and parity-stratified outcomes are presented.
COH, controlled ovarian hyperstimulation; hMG, human menopausal gonadotropin; HP-hMG, highly-purified hMG; ICSI, intracytoplasmic sperm injection; r-hFSH, recombinant human follicle-stimulating hormone; SD, standard deviation.